Key result
Prior urgent surgery linked to ~2.8-fold higher risk of vascular graft infection following bacteremia.
Why the study?
The incidence and predictors of vascular graft and endograft infection in patients with prior aorto-iliac graft surgery and concurrent bloodstream infection needed to be assessed.
Observational (n=418)
In patients with prior aorto-iliac graft or endograft surgery, the 3-month incidence of graft infection following a bloodstream infection is 7.5%, with significantly higher risk associated with prior urgent surgery, elevated baseline C-reactive protein, and specific pathogens (S. aureus, C. albicans, Actinomycetales, and L. monocytogenes).
Answers are grounded in this paper and cite their sources.
Warrants vigilance for graft infection after bloodstream infection in aorto-iliac patients; leaves open prospective validation of predictors.
Objective To assess incidence and predictors of vascular graft and endograft infection in patients with prior aorto-iliac graft surgery and concurrent blood stream infection. Methods A population-based observational study was conducted in Skåne, Sweden, between 2010–2022. Patients with prior aorto-iliac graft or endograft surgery were identified in the Swedish Vascular Registry and linked to local blood culture data. Electronic medical records were reviewed according to a predefined protocol and vascular graft and endograft infection was assessed using MAGIC-criteria. Fine-Gray models were used to evaluate predictors of vascular graft and endograft infection diagnosis within three months of a bloodstream infection episode. Results A total of 418 patients were identified with 569 bloodstream infection episodes. Of 569 bloodstream infection episodes, 83% (n=473) occurred in men and mean age was 74.9 ± 9 years. The 3-month incidence of vascular graft and endograft infection diagnosis was 7.5%. Elevated C-reactive protein at bloodstream infection onset (sHR; 1.004, 95% CI 1.002–1.007, p<.001) and prior urgent aorto-iliac index surgery (sHR 2.77, 95% CI 1.31-5.87, p=.007) were positively associated with vascular graft and endograft infection. C. albicans (sHR 3.97, 95% CI 1.3–12.1, p=.02), Actinomycetales (sHR 8.29, 95% CI 2.3–29.84, p=0.001), L. monocytogenes (sHR 18.22, 95% CI 11.21-29.63, p <.001) or S. aureus (sHR 1.98, 95% CI 1.05–3.72, p=.03) bloodstream infections were positively associated with vascular graft and endograft infection. Conclusion The 3-month incidence of vascular graft and endograft infection diagnosis after bloodstream infection was 7.5%. Clinical suspicion of vascular graft and endograft infection should be higher in patients with prior urgent aorto-iliac surgery, markedly elevated levels of C-reactive protein at index culture, or bloodstream infection with S. aureus, Actinomycetales, L. monocytogenes or C. albicans.
No takes yet. Share an insight, caveat, or question.
Cewers et al. (2026) conducted an observational in Prior aorto-iliac graft or endograft surgery and concurrent bloodstream infection (n=418). Bloodstream infection and clinical/microbiological risk factors (e.g., prior urgent surgery, elevated CRP, specific pathogens) was evaluated on 3-month incidence of vascular graft and endograft infection diagnosis (assessed using MAGIC-criteria) (sHR 2.77, 95% CI 1.31-5.87, p=.007). Bloodstream infection in patients with prior aorto-iliac graft surgery resulted in a 7.5% 3-month incidence of graft infection, predicted by prior urgent surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: